Highlights
- •Patients with multiple sclerosis (MS) frequently complain of fatigue
- •Neurologists use non-FDA approved prescription drugs early in fatigue treatment
- •These types of drugs may be more dangerous than and only as effective as placebo
- •Physicians may underrecognize the placebo effect in MS fatigue treatment
- •Doctors should use coenzyme Q10 earlier and avoid prescription drugs for MS fatigue
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Multiple Sclerosis and Related DisordersAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Multiple sclerosis-related fatigue lacks a unified definition: A narrative review.J Res Med Sci. 2022 Mar 17; 27 (PMID: 35419061PMCID: PMC8995308): 24https://doi.org/10.4103/jrms.jrms_1401_20
- Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.Lancet Neurol. 2021 Jan; 20 (Epub 2020 Nov 23PMID: 33242419PMCID: PMC7772747): 38-48https://doi.org/10.1016/S1474-4422(20)30354-9
- Are drugs for multiple sclerosis fatigue just placebos?.Lancet Neurol. 2021 Jan; 20 (Epub 2020 Nov 23PMID: 33242420): 20-21https://doi.org/10.1016/S1474-4422(20)30415-4
- Phronesis in Medical Ethics: Courage and Motivation to Keep on the Track of Rightness in Decision-Making.Health Care Anal. 2020 Jun; 28 (PMID: 32356112PMCID: PMC7319403): 158-175https://doi.org/10.1007/s10728-020-00398-7
- Biological, clinical, and ethical advances of placebo effects.Lancet. 2010 Feb 20; 375 (PMID: 20171404PMCID: PMC2832199): 686-695https://doi.org/10.1016/S0140-6736(09)61706-2
- Meta-analysis of the placebo response in antidepressant trials.J. Affect. Disord. 2009 Nov; 118 (Epub 2009 Feb 26PMID: 19246102): 1-8https://doi.org/10.1016/j.jad.2009.01.029
- Psychiatrists' Attitudes Toward Non-Pharmacologic Factors Within the Context of Antidepressant Pharmacotherapy.Acad. Psychiatry. 2016 Oct; 40 (Epub 2015 Dec 8PMID: 26646406PMCID: PMC4899297): 783-789https://doi.org/10.1007/s40596-015-0470-2
- Coenzyme Q10 effects in neurological diseases.Physiol. Res. 2021 Dec 30; 70 (SuppPMID: 35199552): S683-S714https://doi.org/10.33549/physiolres.934712
- Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.Nutr. Neurosci. 2016; 19 (Epub 2015 Jan 20PMID: 25603363): 138-143https://doi.org/10.1179/1476830515Y.0000000002
Article info
Publication history
Published online: July 02, 2022
Accepted:
July 1,
2022
Received in revised form:
June 13,
2022
Received:
April 30,
2022
Identification
Copyright
© 2022 Elsevier B.V. All rights reserved.
